Breaking News Instant updates and real-time market news.

RVNC

Revance

$33.65

-1.1 (-3.17%)

08:39
12/07/17
12/07
08:39
12/07/17
08:39

Revance 5.4M share Secondary priced at $31.00

The deal size was lowered to $150M in common stock from $175M in common stock. Goldman Sachs and Cowen acted as joint book running managers for the offering.

  • 07

    Dec

RVNC Revance
$33.65

-1.1 (-3.17%)

12/05/17
PIPR
12/05/17
NO CHANGE
Target $51
PIPR
Overweight
Piper ups Revance price target to $51 on 'impressive' data
Piper Jaffray analyst David Amsellem raised his price target for Revance Therapeutics (RVNC) to $51 from $28 saying this morning's Phase III results for RT002 are "impressive." The stock in afternoon trading is up 38%, or $10.00, to $36.00. The company can now credibly claim that its "frown lines" treatment confers "significant benefit" for a sizable group of patients out to six months, Amsellem tells investors in an intraday research note. He thinks RT002 could offer the potential not only for less frequent procedures compared to Allergan's (AGN) Botox but also the potential for better treatment outcomes. Allergan in afternoon trading is down $2.13 to $164.72. The analyst believes the question now for RT002 is not approvability, but rather what a differentiated label would look like. Amsellem also feels the data "should embolden" Revance to "cast a wider net in terms of the pursuit of additional indications." He reiterates an Overweight rating on the shares.
12/05/17
GUGG
12/05/17
INITIATION
Target $42
GUGG
Buy
Revance initiated with a Buy at Guggenheim
Guggenheim analyst Rohit Vanjani initiated Revance with a Buy and $42 price target.
12/05/17
WELS
12/05/17
NO CHANGE
WELS
Outperform
Allergan selloff on Revance data overdone, says Wells Fargo
Wells Fargo analyst David Maris views the selloff today in shares of Allergan (AGN) following Revance Therapeutics' (RVNC) frown lines data as overdone. While the positive Phase III results are good news for Revance, the data are yet to be seen in detail and it is unclear how significant a competitor RT002 could be to Allergan's Botox, Maris tells investors in a post-close research note. The analyst says that while RT002 showed statistically significant results at week 24 versus placebo in a key secondary endpoint, the measurement of this endpoint does not seem to match the FDA's published draft guidance. As such, it is unclear if the data will be enough to get a six-month duration claim on the RT002 label, Maris argues. The analyst keeps an Outperform rating on Allergan shares, which closed the trading day down $2.62 to $164.28.
12/06/17
MSCO
12/06/17
NO CHANGE
MSCO
Overweight
Morgan Stanley maintains Botox sales projections after Revance drug data
While Morgan Stanley analyst David Risinger said Revance (RVNC) presented "compelling" Phase 3 investigator-assessed responder rates for RT002 compared to Allergan's (AGN) Botox, he contends that patient-assessed rates, which look much closer in comparison, may be more reflective of potential uptake. Risinger, who believes aesthetics market retreatment decisions will mainly be determined by patients, maintains his Botox sales projections and Overweight rating on Allergan after yesterday's report of data from its competitor.

TODAY'S FREE FLY STORIES

MNK

Mallinckrodt

$30.92

-0.17 (-0.55%)

17:11
11/14/18
11/14
17:11
11/14/18
17:11
Hot Stocks
Mallinckrodt reports on FDA advisory committee findings on Roxicodone »

SpecGx LLC, a subsidiary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 16

    Nov

EYE

National Vision

$41.79

0.72 (1.75%)

17:08
11/14/18
11/14
17:08
11/14/18
17:08
Syndicate
National Vision files to sell 12.5M shares of common stock for holders »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPG

PPG

$105.35

1.03 (0.99%)

, MDLZ

Mondelez

$43.76

-0.33 (-0.75%)

17:08
11/14/18
11/14
17:08
11/14/18
17:08
Hot Stocks
Trian raises stakes in PPG Industries, GE, cuts stake in Sysco in Q3 »

Nelson Peltz's Trian…

PPG

PPG

$105.35

1.03 (0.99%)

MDLZ

Mondelez

$43.76

-0.33 (-0.75%)

GE

General Electric

$8.34

-0.265 (-3.08%)

SYY

Sysco

$66.47

-0.45 (-0.67%)

PG

Procter & Gamble

$93.50

0.03 (0.03%)

BK

BNY Mellon

$48.25

0.05 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 03

    Mar

WPM

Wheaton Precious Metals

$15.97

0.25 (1.59%)

17:05
11/14/18
11/14
17:05
11/14/18
17:05
Hot Stocks
Wheaton Precious Metals sees 2018 gold production 355K ounces »

Wheaton's estimated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

TER

Teradyne

$34.90

0.88 (2.59%)

17:05
11/14/18
11/14
17:05
11/14/18
17:05
Hot Stocks
Teradyne to transfer stock listing to Nasdaq from NYSE »

Teradyne announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

ACBI

Atlantic Capital

$15.40

-0.62 (-3.87%)

17:05
11/14/18
11/14
17:05
11/14/18
17:05
Hot Stocks
Atlantic Capital announces $85M stock repurchase plan »

Atlantic Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

FBK

FB Financial

$37.72

-0.65 (-1.69%)

, ACBI

Atlantic Capital

$15.40

-0.62 (-3.87%)

17:04
11/14/18
11/14
17:04
11/14/18
17:04
Hot Stocks
FB Financial acquires branches from Atlantic Capital Bank »

FB Financial (FBK)…

FBK

FB Financial

$37.72

-0.65 (-1.69%)

ACBI

Atlantic Capital

$15.40

-0.62 (-3.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 05

    Dec

  • 06

    Dec

  • 06

    Dec

WPM

Wheaton Precious Metals

$15.97

0.25 (1.59%)

17:04
11/14/18
11/14
17:04
11/14/18
17:04
Earnings
Wheaton Precious Metals reports Q3 adjusted EPS 8c, consensus 10c »

Reports Q3 revenue $186M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ZTO

ZTO Express

$16.08

0.26 (1.64%)

17:03
11/14/18
11/14
17:03
11/14/18
17:03
Hot Stocks
ZTO Express announces up to $500M share repurchase program »

ZTO Express announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

ZTO

ZTO Express

$16.08

0.26 (1.64%)

17:03
11/14/18
11/14
17:03
11/14/18
17:03
Earnings
ZTO Express sees Q4 adjusted net income RMB1.2B-RMB1.3B »

Sees Q4 parcel volume up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

ZTO

ZTO Express

$16.08

0.26 (1.64%)

17:02
11/14/18
11/14
17:02
11/14/18
17:02
Earnings
ZTO Express reports Q3 earnings per ADS RMB1.35 vs RMB1.00 last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

AVYA

Avaya

$15.75

-0.09 (-0.57%)

17:01
11/14/18
11/14
17:01
11/14/18
17:01
Hot Stocks
Avaya announces $15M warrant repurchase program »

Avaya Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 12

    Dec

MTEX

Mannatech

$16.70

(0.00%)

17:00
11/14/18
11/14
17:00
11/14/18
17:00
Hot Stocks
Mannatech authorizes $500,000 share repurchase program »

Mannatech announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STT

State Street

$70.34

-0.71 (-1.00%)

, WMB

Williams

$24.75

0.43 (1.77%)

16:57
11/14/18
11/14
16:57
11/14/18
16:57
Hot Stocks
Appaloosa takes new Apple stake, exits Wells, Ally, UBS in Q3 »

David Tepper's…

STT

State Street

$70.34

-0.71 (-1.00%)

WMB

Williams

$24.75

0.43 (1.77%)

AAPL

Apple

$186.81

-5.42 (-2.82%)

WFC

Wells Fargo

$52.15

-0.59 (-1.12%)

ALLY

Ally Financial

$25.40

-0.17 (-0.66%)

UBS

UBS

$13.70

0.055 (0.40%)

KEY

KeyCorp

$18.22

-0.2 (-1.09%)

WDC

Western Digital

$45.06

0.38 (0.85%)

PCG

PG&E

$25.66

-7.04 (-21.53%)

NRG

NRG Energy

$39.03

-0.37 (-0.94%)

VST

Vistra Energy

$23.83

-0.49 (-2.01%)

BYD

Boyd Gaming

$24.62

1 (4.23%)

MU

Micron

$38.03

0.17 (0.45%)

FB

Facebook

$144.25

2.06 (1.45%)

BABA

Alibaba

$150.55

3.72 (2.53%)

AGN

Allergan

$157.71

-4.925 (-3.03%)

GOOG

Alphabet

$1,043.53

7.2 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 15

    Nov

  • 16

    Nov

  • 19

    Nov

  • 28

    Nov

  • 04

    Dec

  • 17

    Jan

  • 03

    Mar

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

KREF

KKR Real Estate Finance

$20.56

-0.06 (-0.29%)

16:53
11/14/18
11/14
16:53
11/14/18
16:53
Syndicate
KKR Real Estate Finance files to sell 4.5M shares of common stock »

Consisting of 500,000…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORN

Orion Group

$4.60

0.01 (0.22%)

16:52
11/14/18
11/14
16:52
11/14/18
16:52
Hot Stocks
Orion Group award dredging contract of approximately $13M »

Orion Group announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEX

Wex

$157.62

-4.01 (-2.48%)

16:49
11/14/18
11/14
16:49
11/14/18
16:49
Earnings
Wex sees long term revenue growth of 10%-15% adjusted net income up 15%-20% »

Guidance from Wex…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CASI

Casi Pharmaceuticals

$3.33

0.025 (0.76%)

16:47
11/14/18
11/14
16:47
11/14/18
16:47
Syndicate
Casi Pharmaceuticals files to sell 9.09M shares of common stock for holders »

The shares consist of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:46
11/14/18
11/14
16:46
11/14/18
16:46
General news
API crude inventories for week of November 9 »

API reports that crude…

AJX

Great Ajax

$13.70

0.05 (0.37%)

16:45
11/14/18
11/14
16:45
11/14/18
16:45
Syndicate
Great Ajax files to sell convertible senior notes due 2024, no amount given »

The Notes represent an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:45
11/14/18
11/14
16:45
11/14/18
16:45
General news
Breaking General news story  »

Dallas Federal Reserve…

16:45
11/14/18
11/14
16:45
11/14/18
16:45
General news
Breaking General news story  »

Federal Reserve Chairman…

BBT

BB&T

$50.54

-0.53 (-1.04%)

16:44
11/14/18
11/14
16:44
11/14/18
16:44
Earnings
BB&T sees FY19 revenue growth up 2%-4% »

Sees FY19 credit loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 18

    Oct

ADP

ADP

$142.75

-2.11 (-1.46%)

16:43
11/14/18
11/14
16:43
11/14/18
16:43
Hot Stocks
Breaking Hot Stocks news story on ADP »

Ackman's Pershing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$95.02

-0.61 (-0.64%)

, UTX

United Technologies

$128.89

-0.245 (-0.19%)

16:41
11/14/18
11/14
16:41
11/14/18
16:41
Hot Stocks
Breaking Hot Stocks news story on Lowe's, United Technologies »

Ackman's Pershing…

LOW

Lowe's

$95.02

-0.61 (-0.64%)

UTX

United Technologies

$128.89

-0.245 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.